Each month, ALS TDI brings together researchers from our lab and others for a conversation about an important topic to
patients today. These can be on a specific trial, an emerging technology, or a broad theory gaining notoriety in the effort
to combat ALS. These conversations are designed to ask these researchers direct questions and to provide a place where YOU and
YOUR family can speak directly to those working on your behalf at ALS TDI and other labs. These webinars are recorded, but we
encourage folks to join us live as your questions and interaction with these researchers is incredibly important.
1. Who we are?
2. What's being tested in the lab today?
3. High-level knowledge of our approach to responding
to the ALS crisis
The webinar will last on average 30 minutes and the presenters will be available for up to an hour afterwards for
questions. Questions can be entered online in a chat box or over the phone. You will be provided the dial-in and
log-on information after you register. We ask that you register at least two hours before a scheduled webinar. You
need not download any software to participate.
ALS TDI Research Updates
These calls are hosted by ALS TDI's CEO & Chief Scientific Officer, Steven Perrin, Ph.D., and other members of the ALS TDI
research team. These calls provide patients and their families an opportunity to ask specific questions of several members
of our staff at one time. They also allow ALS TDI to provide information about our work over the internet in an interactive
format. No other nonprofit organization that provides as much in-depth reporting on its research progress in the way to the
ALS community than ALS TDI.
This is not an introductory seminar. Most topics discussed will require a greater understanding of the disease than
normal. Participants will receive an agenda and topic list in advance, but topics range from current therapeutics in the
ALS TDI lab, review of scientific publications and updates on scientific collaborations, as well as a high level overview
of milestones that have been reached. It is strongly advised that you participate in an Introduction of ALS Research Webinar
or ALS Research 101 Seminar prior to participating in one of these Research Updates.
For general or registration questions, please email email@example.com.